2) MAKINO Y. Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. (2010) vol.126, p.1163-9.e5.
3) NAGAO M. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol. (2008) vol.146, no.Suppl 1, p.47-53.
4) JAMES LK. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. (2011) vol.127, p.509-16.el-5.